Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

ESMO 2010

8 - 12 Oct 2010
Hotel Porto Bay Falesia, Algarve, Portugal
Denosumab treatment of skeletal related events
Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA
Denosumab treatment of skeletal related events ( Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA )
8 Feb 2011
The Spectrum Study
Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium
The Spectrum Study ( Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium )
8 Feb 2011
CHOICE study and the importance of quality assurance in oncology
Prof Simon van Belle - University Hospital Ghent, Ghent, Belgium
CHOICE study and the importance of quality assurance in oncology ( Prof Simon van Belle - University Hospital Ghent, Ghent, Belgium )
8 Feb 2011
Treatment of brain metastases in melanoma patients
Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Egg...
Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )
7 Feb 2011
The role of bevacizumab in the treatment of ovarian cancer
Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - F...
The role of bevacizumab in the treatment of ovarian cancer ( Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - Fox Chase Cancer Center, Philadelphia, USA; Prof Nicoletta Colombo - European Institute of Oncology, Milan, Italy )
7 Feb 2011
Supportive care for patients with locally advanced disease
Prof Dirk Schrijvers - Ziekenhuisnetwerk Antwerpen Middelheim, Antwerp, Belgium
Supportive care for patients with locally advanced disease ( Prof Dirk Schrijvers - Ziekenhuisnetwerk Antwerpen Middelheim, Antwerp, Belgium )
2 Feb 2011
Tumour immunology and combined immunotherapies
Prof Ignacio Melero - University of Navarra, Pamplona, Spain
Tumour immunology and combined immunotherapies ( Prof Ignacio Melero - University of Navarra, Pamplona, Spain )
2 Feb 2011
SPECTRUM trial for squamous cell carcinoma of the head and neck
Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA
SPECTRUM trial for squamous cell carcinoma of the head and neck ( Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA )
31 Jan 2011
A new treatment for fractured vertebrae and the antiemetic efficacy of palonoset...
Prof Fausto Roila - Terni Hospital, Italy
A new treatment for fractured vertebrae and the antiemetic efficacy of palonosetron ( Prof Fausto Roila - Terni Hospital, Italy )
31 Jan 2011
Clinical benefits and side effects of ipilimumab in melanoma patients
Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy
Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )
31 Jan 2011
Molecular biomarkers and acquired resistance to new target agents
Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy
Molecular biomarkers and acquired resistance to new target agents ( Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy )
31 Jan 2011
Active monitoring of prostate cancer
Prof Sten Nilsson - Karolinska Institutet, Stockholm, Sweden
Active monitoring of prostate cancer ( Prof Sten Nilsson - Karolinska Institutet, Stockholm, Sweden )
28 Jan 2011
The East European Sarcoma Group
Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow
The East European Sarcoma Group ( Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow )
25 Jan 2011
Soft Tissue Sarcoma management in Turkey
Berksoy Sahin - Çukurova University Medical School, Adana-Turkey
Soft Tissue Sarcoma management in Turkey ( Berksoy Sahin - Çukurova University Medical School, Adana-Turkey )
25 Jan 2011
Oncotype DX testing to determine adjuvant therapy for breast cancer patients
Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain
Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )
25 Jan 2011
Oncotype DX testing to determine adjuvant therapy for breast cancer patients
Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain
Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )
24 Jan 2011
Media reporting of cancer
ECCO's Patient Advisory Committee
Media reporting of cancer ( ECCO's Patient Advisory Committee )
24 Nov 2010
Influence of electronic media on the communication of cancer issues
ECCO's Patient Advisory Committee
Influence of electronic media on the communication of cancer issues ( ECCO's Patient Advisory Committee )
24 Nov 2010
Accurate balanced reporting of cancer information
ECCO's Patient Advisory Committee
Accurate balanced reporting of cancer information ( ECCO's Patient Advisory Committee )
24 Nov 2010
Patient needs that should be met by patient advocates and web resources
ECCO's Patient Advisory Committee
Patient needs that should be met by patient advocates and web resources ( ECCO's Patient Advisory Committee )
24 Nov 2010
Clinical trials evaluating treatment of colorectal cancer
Prof Alberto Sobrero - San Martino Hospital, Genoa, Italy
Clinical trials evaluating treatment of colorectal cancer ( Prof Alberto Sobrero - San Martino Hospital, Genoa, Italy )
24 Nov 2010
Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
10 Nov 2010
How to select targeted therapy in renal cancer
Prof Bernard Escudier - Institut Gustave Roussy, Paris, France
How to select targeted therapy in renal cancer ( Prof Bernard Escudier - Institut Gustave Roussy, Paris, France )
10 Nov 2010
The development of PARP inhibitors a new drug to treat prostate cancer
Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, S...
The development of PARP inhibitors a new drug to treat prostate cancer ( Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK )
10 Nov 2010
Treatment of neuroendocrine tumours with everolimus
Dr Nicola Fazio - European Institute of Oncology, Milan, Italy
Treatment of neuroendocrine tumours with everolimus ( Dr Nicola Fazio - European Institute of Oncology, Milan, Italy )
10 Nov 2010
The impact of mapping the human genome on cancer therapies
Dr Kevin Davies - Bio-IT World, Massachusetts, USA
The impact of mapping the human genome on cancer therapies ( Dr Kevin Davies - Bio-IT World, Massachusetts, USA )
10 Nov 2010
The role of genetic testing within oncology
Dr James Mackay - University College London, UK
The role of genetic testing within oncology ( Dr James Mackay - University College London, UK )
10 Nov 2010
A new partnership between OECI and ecancer.tv
Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and...
A new partnership between OECI and ecancer.tv ( Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and Alleanza Contro il Cancro, Rome, Italy )
10 Nov 2010
A multimedia information service for cancer patients
Prof Francesco De Lorenzo - Federico II University of Naples, Italy
A multimedia information service for cancer patients ( Prof Francesco De Lorenzo - Federico II University of Naples, Italy )
10 Nov 2010
Implementation of ESMO guidelines
Prof Andrés Cervantes - University of Valencia, Spain
Implementation of ESMO guidelines ( Prof Andrés Cervantes - University of Valencia, Spain )
10 Nov 2010
GOG-218: Bevacizumab plus standard chemo for ovarian cancer
Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )
10 Nov 2010
Pain management and the treatment of cancer patients with low blood counts
Prof Dorothy Keefe - The University of Adelaide, Australia
Pain management and the treatment of cancer patients with low blood counts ( Prof Dorothy Keefe - The University of Adelaide, Australia )
10 Nov 2010
Bevacizumab as part of standard first line treatment of ovarian cancer
Prof Jonathan Ledermann - University College London, UK
Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
10 Nov 2010
Optimal treatment for colorectal cancer patients with liver metastases
Prof Peter Naredi - Umea University, Sweden
Optimal treatment for colorectal cancer patients with liver metastases ( Prof Peter Naredi - Umea University, Sweden )
10 Nov 2010
OECI Accreditation
Dr Mahasti Saghatchian - Institut Gustave Roussy, Villejuif, France
OECI Accreditation ( Dr Mahasti Saghatchian - Institut Gustave Roussy, Villejuif, France )
4 Nov 2010
The treatment of advanced pancreatic neuroendocrine tumours (pNET)
Prof Kjell Öberg - University Hospital, Uppsala, Sweden
The treatment of advanced pancreatic neuroendocrine tumours (pNET) ( Prof Kjell Öberg - University Hospital, Uppsala, Sweden )
4 Nov 2010
The role of The Christie NHS Foundation Trust within OECI
Dr Chris Harrison - The Christie NHS Foundation Trust, Manchester, UK
The role of The Christie NHS Foundation Trust within OECI ( Dr Chris Harrison - The Christie NHS Foundation Trust, Manchester, UK )
4 Nov 2010
Eastern Europe breast cancer screening programme
Dr. Natalia Zakharova - State Research Institute of Genetics, Moscow, Russia
Eastern Europe breast cancer screening programme ( Dr. Natalia Zakharova - State Research Institute of Genetics, Moscow, Russia )
4 Nov 2010
Clinical trial design, biomarkers development and the treatment of neuropathic p...
Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy
Clinical trial design, biomarkers development and the treatment of neuropathic pain ( Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy )
4 Nov 2010
Key research from ESMO 2010
Prof Jim Cassidy - University of Glasgow, UK
Key research from ESMO 2010 ( Prof Jim Cassidy - University of Glasgow, UK )
1 Nov 2010
Care of cancer survivors
Prof Wim van Harten - Netherlands Cancer Institute, Amsterdam, Netherlands
Care of cancer survivors ( Prof Wim van Harten - Netherlands Cancer Institute, Amsterdam, Netherlands )
1 Nov 2010
The ICON7 trial
Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK
The ICON7 trial ( Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK )
1 Nov 2010
PARP inhibitors
Prof Ruth Plummer - Newcastle University, UK
PARP inhibitors ( Prof Ruth Plummer - Newcastle University, UK )
1 Nov 2010
Cancer of unknown primary origin
Prof Nicholas Pavlidis - University of Ioannina, Greece
Cancer of unknown primary origin ( Prof Nicholas Pavlidis - University of Ioannina, Greece )
1 Nov 2010
The ESMO President discusses the congress and future plans for developing countr...
Prof David Kerr - President of ESMO
The ESMO President discusses the congress and future plans for developing countries ( Prof David Kerr - President of ESMO )
22 Oct 2010
ESMO highlights from Prof Gordon McVie - his views on the science presented
Prof Gordon McVie - European Institute of Oncology
ESMO highlights from Prof Gordon McVie - his views on the science presented ( Prof Gordon McVie - European Institute of Oncology )
22 Oct 2010